Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Metered-dose inhaler Stories

2010-03-18 10:11:00

PITTSBURGH, March 18 /PRNewswire/ -- ChemImage, a world leader in chemical imaging products and services, will present the results of an ingredient-specific particle sizing (ISPST) study on a combination Metered Dose Inhaler product at Respiratory Drug Delivery (RDD) 2010 (www.rddonline.com). This conference will take place from April 25th - 29th in Orlando, Florida and will feature thought leaders discussing current biological and pharmaceutical issues related to nasal and respiratory...

2010-03-01 09:00:00

MIDLOTHIAN, Va., March 1 /PRNewswire/ -- Today, PARI Respiratory Equipment launched their newest aerosol delivery system, the Vios. Paired with PARI's gold standard reusable nebulizers, Vios delivers fast treatments, small particle size, and high respirable drug dose to the lungs. Vios also features an extended warranty and Timestrip, an easy to use reminder for patients to replace their nebulizer every six months. "We are excited for physicians treating respiratory diseases to begin...

2010-02-26 07:11:00

HORSHAM, Pa., Feb. 26 /PRNewswire-FirstCall/ -- Increasing evidence supports the importance of small airways in the diagnosis and treatment of asthma; however, focused areas of discussion and critical review of this topic have been lacking. To foster a better understanding of the role of small airways in asthma management, Teva Respiratory, a subsidiary of Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), will be providing reprints of a special supplement entitled "Small Airway...

2010-02-25 05:18:00

GAINESVILLE, Fla., Feb. 25 /PRNewswire/ -- Exponential growth is the term that some electronic cigarette retailers are using to express the increase in sales volume that they are experiencing over the last 6 to 12 months and this growth is continuing despite the corporate sponsored anti-smoking campaign against them. The public has judged the information and test results that have been done on both sides of the arena and seem to be listening to the electronic cigarette side with more...

2010-02-01 07:00:00

REDWOOD CITY, Calif., Feb. 1 /PRNewswire/ -- Pearl Therapeutics Inc., a company developing clinically differentiated combination therapies for the treatment of highly prevalent chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD), today announced a $15 million financing from existing investors Clarus Ventures, New Leaf Venture Partners and 5AM Ventures. The capital was raised through a convertible loan facility that will convert to Pearl equity at the time...

2010-01-26 07:10:00

HORSHAM, Pa., Jan. 26 /PRNewswire/ -- While cold and flu season is always unpredictable, this year is already one of the worst to date with flu outbreaks across the nation stemming from the arrival of the H1N1 virus and another wave of seasonal flu on the horizon. People with asthma or chronic obstructive pulmonary disease (COPD) are at higher risk of developing severe respiratory symptoms if they contract a cold or the flu, and those with asthma account for about one-third of all people...

2010-01-21 07:00:00

SAN DIEGO, Jan. 21 /PRNewswire/ -- Elevation Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of new aerosol therapies for patients with respiratory diseases, announced today the closing of a $30 million tranched Series A financing. Investors participating include Canaan Partners, TPG Growth, Care Capital, and Mesa Verde Venture Partners. Concurrent with this financing, Elevation has added to its board of directors Brent Ahrens, General Partner at Canaan,...

2010-01-06 07:00:00

REDWOOD CITY, Calif., Jan. 6 /PRNewswire/ -- Pearl Therapeutics Inc., a company developing high-quality combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from a Phase 2a dose-ranging study of PT001, the company's glycopyrrolate hydrofluoroalkane metered dose inhaler (HFA-MDI) formulation. The data showed that PT001 was well tolerated and was comparable in bronchodilator efficacy and safety to the active control drug...

2009-12-17 05:20:00

GAINESVILLE, Fla., Dec. 17 /PRNewswire/ -- Over the last few weeks there has been an increase of the amount of scare language that is used by e cigarette opposition in an attempt to scare the population concerning the electronic cigarette. Many are questioning the tactics of these groups when the evidence clearly shows that the product is indeed a safer alternative to tobacco according to several studies, lab reports and opinions from top medial and harm reduction specialist around the...

2009-11-18 10:58:00

NEW YORK, Nov. 18 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Pulmonary Drug Delivery Technologies - A Global Market Perspective http://www.reportlinker.com/p0164238/Pulmonary-Drug-Delivery-Technologies---A-Global-Market-Perspective.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire Until recent years, respiratory conditions such as asthma, chronic obstructive pulmonary, and emphysema disease...


Latest Metered-dose inhaler Reference Libraries

Nicotine Replacement Therapy
2013-03-04 16:06:28

Nicotine replacement therapy is the administration of nicotine by other means than smoking. This change in the way nicotine is delivered prevents the harmful effects of smoking and is usually used in smoking cessation. Types Nicotine replacement therapy can be administered in several forms. The type used depends on the patient and what fits into their lifestyle best. The forms available include: Nicotine patches – transdermal (through the skin) Nicotine gum – orally (through the...

More Articles (1 articles) »